- Home
- WIMI vs EGRX Comparison
WIMI vs EGRX Comparison
Compare WIMI & EGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- EGRX
- Stock Information
- Founded
- WIMI 2015
- EGRX 2007
- Country
- WIMI China
- EGRX United States
- Employees
- WIMI N/A
- EGRX N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- EGRX Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- EGRX Health Care
- Exchange
- WIMI Nasdaq
- EGRX Nasdaq
- Market Cap
- WIMI 74.7M
- EGRX 74.4M
- IPO Year
- WIMI 2020
- EGRX 2014
- Fundamental
- Price
- WIMI $0.76
- EGRX $4.25
- Analyst Decision
- WIMI
- EGRX
- Analyst Count
- WIMI 0
- EGRX 0
- Target Price
- WIMI N/A
- EGRX N/A
- AVG Volume (30 Days)
- WIMI 286.2K
- EGRX 83.3K
- Earning Date
- WIMI 01-01-0001
- EGRX 09-17-2024
- Dividend Yield
- WIMI N/A
- EGRX N/A
- EPS Growth
- WIMI N/A
- EGRX N/A
- EPS
- WIMI N/A
- EGRX 0.91
- Revenue
- WIMI $82,551,712.00
- EGRX $257,551,000.00
- Revenue This Year
- WIMI N/A
- EGRX N/A
- Revenue Next Year
- WIMI N/A
- EGRX N/A
- P/E Ratio
- WIMI N/A
- EGRX $4.66
- Revenue Growth
- WIMI N/A
- EGRX N/A
- 52 Week Low
- WIMI $0.56
- EGRX $3.21
- 52 Week High
- WIMI $1.87
- EGRX $17.32
- Technical
- Relative Strength Index (RSI)
- WIMI 47.17
- EGRX 40.69
- Support Level
- WIMI $0.73
- EGRX $4.35
- Resistance Level
- WIMI $0.81
- EGRX $5.45
- Average True Range (ATR)
- WIMI 0.07
- EGRX 0.38
- MACD
- WIMI -0.00
- EGRX -0.00
- Stochastic Oscillator
- WIMI 16.13
- EGRX 12.41
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About EGRX Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.